Services

Histology

Pharmacology

Medical Device Testing

In Vitro Screening

Animal Model Development

Custom Assay Development

Vivarium Rental

Toxicology

Species

Non-human Primates

Dogs

Mini-pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Career

Request a Quote

Logo
☰
  • Services ⌄
    • Histology
    • Pharmacology
    • Medical Device Testing
    • In Vitro Screening
    • Animal Model Development
    • Custom Assay Development
    • Vivarium Rental
    • Toxicology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Mini-pigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Career
    • Request a Quote

Gilead Elated as the FDA OKs New Blockbuster HIV Pill Biktarvy

  • Post author:Sam
  • Post published:February 7, 2018
  • Post category:BioPharma

The FDA approved Gilead's triple combination treatment for HIV, Biktarvy. Source: BioSpace

Continue ReadingGilead Elated as the FDA OKs New Blockbuster HIV Pill Biktarvy

Interview Insider: Tips on How to Get Hired at Vertex Pharmaceuticals

  • Post author:Sam
  • Post published:February 7, 2018
  • Post category:BioPharma

Here is some insight on what Vertex may be looking for in their employees. Source: BioSpace

Continue ReadingInterview Insider: Tips on How to Get Hired at Vertex Pharmaceuticals

Madrigal's Cholesterol Drug Succeeds in Mid-Stage Trial

  • Post author:Sam
  • Post published:February 7, 2018
  • Post category:BioPharma

MGL-3196 was well-tolerated with primarily mild and some moderate AEs. Source: BioSpace

Continue ReadingMadrigal's Cholesterol Drug Succeeds in Mid-Stage Trial

Ousted Arcturus Founder and CEO Claims He was Improperly Pushed Out by 4 Board Members

  • Post author:Sam
  • Post published:February 6, 2018
  • Post category:BioPharma

Joseph E. Payne was shown the door as CEO of Arcturus last week - a move that Payne is not taking lightly. Source: BioSpace

Continue ReadingOusted Arcturus Founder and CEO Claims He was Improperly Pushed Out by 4 Board Members

2 Bay Area Biotechs That Jumped While Its Peers Cratered

  • Post author:Sam
  • Post published:February 6, 2018
  • Post category:BioPharma

Since Friday, the stock market has been volatile, to say the least. Source: BioSpace

Continue Reading2 Bay Area Biotechs That Jumped While Its Peers Cratered

On a Roll: FDA Calls Sage's Depression Drug a Breakthrough

  • Post author:Sam
  • Post published:February 6, 2018
  • Post category:BioPharma

This is the second Breakthrough Therapy designation granted to Sage since 2016. Source: BioSpace

Continue ReadingOn a Roll: FDA Calls Sage's Depression Drug a Breakthrough

Cambridge's Enumeral Filed for Bankruptcy, Sells Assets to Bay Area's XOMA

  • Post author:Sam
  • Post published:February 6, 2018
  • Post category:BioPharma

It's the end of the road for Cambridge, MA based Enumeral Biomedical. Source: BioSpace

Continue ReadingCambridge's Enumeral Filed for Bankruptcy, Sells Assets to Bay Area's XOMA

Biogen Halts Plans to Develop Tysabri for Stroke After Phase IIb Trial Flop

  • Post author:Sam
  • Post published:February 6, 2018
  • Post category:BioPharma

Natalizumab did not demonstrate improvement in clinical outcomes compared to placebo. Source: BioSpace

Continue ReadingBiogen Halts Plans to Develop Tysabri for Stroke After Phase IIb Trial Flop

GlaxoSmithKline's Booming Pipeline Under CEO Emma Walmsley

  • Post author:Sam
  • Post published:February 6, 2018
  • Post category:BioPharma

Since Emma Walmsley took over leadership at Glaxo, expectations have been both high and hypercritical. Source: BioSpace

Continue ReadingGlaxoSmithKline's Booming Pipeline Under CEO Emma Walmsley

Another Day, Another Breakthrough Tag for GlaxoSmithKline's Bexsero

  • Post author:Sam
  • Post published:February 6, 2018
  • Post category:BioPharma

Bexsero is the first vaccine in the world to receive the designation twice. Source: BioSpace

Continue ReadingAnother Day, Another Breakthrough Tag for GlaxoSmithKline's Bexsero
  • Go to the previous page
  • 1
  • …
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • …
  • 288
  • Go to the next page

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:

6042 Cornerstone Court W

Suite E

San Diego, CA 92121

Social:
© 2025 BioLegacy Research. All rights reserved.